China National Accord Medicines Corporation Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 18,686.82 million compared to CNY 17,150.86 million a year ago. Net income was CNY 362.21 million compared to CNY 252.36 million a year ago.

Basic earnings per share from continuing operations was CNY 0.6538 compared to CNY 0.4538 a year ago.